ES2169041T3 - Metodo para el tratamiento de la hiperpigmentacion en la piel negra con acido retinoico y metodo para aclarar la piel negra con acido retinoico. - Google Patents

Metodo para el tratamiento de la hiperpigmentacion en la piel negra con acido retinoico y metodo para aclarar la piel negra con acido retinoico.

Info

Publication number
ES2169041T3
ES2169041T3 ES93908528T ES93908528T ES2169041T3 ES 2169041 T3 ES2169041 T3 ES 2169041T3 ES 93908528 T ES93908528 T ES 93908528T ES 93908528 T ES93908528 T ES 93908528T ES 2169041 T3 ES2169041 T3 ES 2169041T3
Authority
ES
Spain
Prior art keywords
retinoic acid
black skin
treatment
hyperpigmentation
black
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93908528T
Other languages
English (en)
Inventor
John J Voorhees
Charles N Ellis
Christopher E M Griffiths
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan filed Critical University of Michigan
Application granted granted Critical
Publication of ES2169041T3 publication Critical patent/ES2169041T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA HIPERPIGMENTACION DE LA PIEL NEGRA PUEDE TRATARSE MEDIANTE LA APLICACION TOPICA DE ACIDO RETINOICO A LA PIEL. LA APLICACION TOPICA DEL ACIDO RETINOICO TAMBIEN ES EFECTIVA PARA ACLARAR LA PIEL NEGRA NORMAL.
ES93908528T 1992-03-31 1993-03-31 Metodo para el tratamiento de la hiperpigmentacion en la piel negra con acido retinoico y metodo para aclarar la piel negra con acido retinoico. Expired - Lifetime ES2169041T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/861,133 US5750570A (en) 1992-03-31 1992-03-31 Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid

Publications (1)

Publication Number Publication Date
ES2169041T3 true ES2169041T3 (es) 2002-07-01

Family

ID=25334976

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93908528T Expired - Lifetime ES2169041T3 (es) 1992-03-31 1993-03-31 Metodo para el tratamiento de la hiperpigmentacion en la piel negra con acido retinoico y metodo para aclarar la piel negra con acido retinoico.

Country Status (8)

Country Link
US (2) US5750570A (es)
EP (1) EP0633773B1 (es)
AT (1) ATE209484T1 (es)
AU (1) AU3931993A (es)
DE (1) DE69331230T2 (es)
ES (1) ES2169041T3 (es)
SG (1) SG50440A1 (es)
WO (1) WO1993019743A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750570A (en) * 1992-03-31 1998-05-12 The Regents Of The University Of Michigan Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid
US5401517A (en) * 1993-11-15 1995-03-28 Elizabeth Arden Company, Division Of Conopco, Inc. Cosmetic method for treatment of skin
US5599548A (en) * 1995-05-08 1997-02-04 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides and retinol or retinyl ester
US5536740A (en) * 1995-06-01 1996-07-16 Elizabeth Arden Company, Division Of Conopco, Inc. Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US5716627A (en) * 1996-04-25 1998-02-10 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
US5693330A (en) * 1996-04-25 1997-12-02 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing melinamide and a retinoid
US5744148A (en) * 1996-09-20 1998-04-28 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stabilization of an unstable retinoid in oil-in-water emulsions for skin care compositions
US5955092A (en) * 1996-09-27 1999-09-21 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP0908179A1 (en) * 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
GB9918022D0 (en) 1999-07-30 1999-09-29 Unilever Plc Skin care composition
AP2002002534A0 (en) * 1999-11-09 2002-06-30 Univ Michigan Regents A method of treating and lightening hyperpigmentation in black skin with a retinoid.
WO2001066080A1 (en) * 2000-03-07 2001-09-13 Avon Products, Inc. Methods using phytol to improve the appearance of skin and compositions for such methods
US20040043044A1 (en) 2000-06-30 2004-03-04 Granger Stewart Paton Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid
US20050154407A1 (en) * 2000-12-20 2005-07-14 Fox Hollow Technologies, Inc. Method of evaluating drug efficacy for treating atherosclerosis
US6949247B2 (en) 2000-12-28 2005-09-27 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stable skin care compositions containing a retinoid and a retinoid booster system
US6565864B2 (en) 2000-12-28 2003-05-20 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Skin care product containing retinoids and phytoestrogens in a dual compartment package
WO2004043469A1 (en) 2001-11-16 2004-05-27 Klysz Beatrice M Anti-aging skin care composition and uses thereof
US20030212077A1 (en) * 2002-05-08 2003-11-13 Birnbaum Jay E. Methods and compositions for treating tinea versicolor using combinations of retinoids and certain antifungals
JP2004020220A (ja) * 2002-06-12 2004-01-22 Pioneer Electronic Corp 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム
DE102004016250A1 (de) * 2004-04-02 2005-10-20 Merck Patent Gmbh Chromon-Komplexe
US7794413B2 (en) * 2005-04-19 2010-09-14 Ev3, Inc. Libraries and data structures of materials removed by debulking catheters
DE102007013366A1 (de) 2007-03-16 2008-09-18 Merck Patent Gmbh Verwendung von Chroman-4-on-Derivaten
EP1977743B1 (en) 2007-03-20 2009-09-02 Johnson & Johnson Consumer France SAS Compositions containing retinoid and beta-aminoisobutyric acid derivates
ES2327201B1 (es) 2008-04-23 2010-07-23 Ignacio Umbert Millet Composicion farmaceutica personalizada para el rejuvenecimiento de la piel que contiene acido retinoico.
DE102010054149A1 (de) 2010-12-10 2012-06-14 Merck Patent Gmbh 2-Pyrone
ES2378028B1 (es) 2012-02-22 2013-02-18 Ignacio Umbert Millet Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes
FR3067933B1 (fr) * 2017-06-21 2020-07-17 L'oreal Modulateurs de l’opsine 3 dans la modulation de la pigmentation de la peau

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750570A (en) * 1992-03-31 1998-05-12 The Regents Of The University Of Michigan Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid
US5266307A (en) * 1992-03-31 1993-11-30 The Regents Of The University Of Michigan Retinoic acid as a skin tanning agent in persons of light skin color

Also Published As

Publication number Publication date
US5750570A (en) 1998-05-12
DE69331230T2 (de) 2002-08-29
EP0633773B1 (en) 2001-11-28
DE69331230D1 (de) 2002-01-10
WO1993019743A1 (en) 1993-10-14
SG50440A1 (en) 1998-07-20
US6017960A (en) 2000-01-25
EP0633773A4 (en) 1994-11-09
AU3931993A (en) 1993-11-08
EP0633773A1 (en) 1995-01-18
ATE209484T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
ES2169041T3 (es) Metodo para el tratamiento de la hiperpigmentacion en la piel negra con acido retinoico y metodo para aclarar la piel negra con acido retinoico.
NZ331237A (en) Superficial chemical skin peels using salicyclic acid
CO4900023A1 (es) Composiciones cosmeticas substancialmente libres de compues- tos
HK59493A (en) Dermatological,pharmaceutical or cosmetic composition consisting of hydrated lipid lamellar phases or liposomes and containing retinoids or analogues such as carotenoids
KR950031034A (ko) 화장품 또는 피부과용 조성물 및 그의 제법
MX9702920A (es) Composiciones para el cuidado de la piel que contienen amidas de acido graso, azoles y retinol o ester retinilico.
CA2175581A1 (en) Desquamation compositions containing salicylic acid and zwitterionic compounds
BR9803281A (pt) Composição contendo hidróxi-ácido e reinóide; e; processo cosmético para reduzir picada ou irritação induzida pela aplicação local de uma composição contendo um hidróxi-ácido ou um retinóide.
ES2168334T3 (es) Composicion para el tratamiento de la piel.
ES2167516T3 (es) Composiciones para el cuidado de la piel que contienen dimetilimidazolidinona y retinol o ester de retinilo.
CY1107732T1 (el) Συνθεση αποπηγμεντωσης για το δερμα περιλαμβανουσα αδαπαλενιο και ενα τουλαχιστον παραγοντα αποπηγμεντωσης
ES2166862T3 (es) Composiciones para el cuidado de la piel que contienen amidas de acidos grasos y retinol o esteres de retinilo.
MY130044A (en) Retinoid composition
AR009096A1 (es) UNA COMPOSICIoN PARA EL CUIDADO DE LA PIEL QUE CONTIENE COMBINACIONES DE COMPUESTOS PARA IMITAR EL EFECTO EN LA PIEL DEL ACIDO RETINOICO Y METODOS COSMETICOS, NO TERAPEUTICOS, PARA EL ACONDICIONAMIENTO DE LA PIEL QUE COMPRENDEN LA APLICACIoN DE DICHA COMPOSICIoN Y LA IMITACIoN DEL EFECTO DEL ACIDO R
EP0803247A3 (en) Skin care compositions containing a retinoid
CA2004861A1 (en) Dermal uses of non-irritating retinoids
AU5132799A (en) Short contact treatment of acne and photoaging with topical retinoids
AP2002002534A0 (en) A method of treating and lightening hyperpigmentation in black skin with a retinoid.
Cotellessa et al. Microabrasion versus microabrasion followed by 15% trichloroacetic acid for treatment of cutaneous hyperpigmentations in adult females
MX9804118A (es) Tratamiento dermico con esteres de acido salicilico y compuestos retinoides.
HK1004888A1 (en) Synergistic skin depigmentation composition
IL94914A0 (en) Resolution of threo-3-((2-aminophenyl)thio)-2-hydroxy-3-(4-methoxyphenyl)propionic acid
Zimmer Effects of low pH acclimation on cladocerans: Clues to the interaction of physiology and ecology of acid lake zooplankton.
JPS53113025A (en) Proliferation inhibitor for microorganisms
JPS53133892A (en) Auxiliary apparatus for emergency stopping of ship

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 633773

Country of ref document: ES